Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab for Pain in Interstitial Cystitis/Painful Bladder Syndrome
NCT00999518Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2010
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 2 trial of tanezumab in interstitial cystitis (IC), sponsored by Pfizer. Started Jan 2010; status: terminated.
02
Drugs
tanezumab
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00999518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999518.